Tiziana Life Sciences Ltd is a biotechnology company focused on developing innovative therapies for diseases with significant unmet medical needs

Their research is primarily centered on the application of monoclonal antibodies and other biological agents to address conditions such as cancer, autoimmune disorders, and infectious diseases. By leveraging cutting-edge science and technology, Tiziana aims to create novel solutions that enhance patient outcomes and improve the quality of life for individuals suffering from debilitating health issues. The company is actively engaged in clinical trials and collaborations to bring their advancements from the lab to the clinic.